Exploring Undiscovered and Undervalued Stocks Look Now: HNRC, VTAK, ENZC, XRTX
https://thestreetreports.com/exploring-undisc...enzc-xrtx/
As the market turned volatile due to on-going war tensions in the Middle East, we have shortlisted a few stocks to watch, which offer impressive valuations: –
Houston Natural Resources Corporation (OTC:HNRC) stock has been hovering around a lower level after hitting a 52-week high of $0.84 in December last year.
The black-check company HNR Acquisition Corp., which had been formed by the oil and gas company, made a major announcement on October 10. Houston Natural announced that it had managed to secure a binding commitment to the tune of $28 million in the form of a secured term loan from Watford City, North Dakota-headquartered First International Bank & Trust (FIBT).
It could be seen as a positive for Houston Natural Resources Corporation as well, and hence, it may be a good time to keep an eye on the stock too. The credit facility would be used to fund a part of the $90 million acquisition of Pogo Resources.
Catheter Precision Inc. (NYSEAMERICAN: VTAK) stock has built up a strong base at a lower level and might see a quick bounce.
On October 12, Catheter Precision Inc. was in focus after it announced that its VIVO 3D mapping system had been granted national reimbursement status in the United Kingdom following its inclusion in the High-Coast Tariff Excluded Devices (HCTED).
HCTED is a supply and purchase system spanning the entire nation for National Health Service England. It had been designed so that products that make the cut for separate payment from the national budget for medical procedures could be paid for.
Enzolytics Inc. (OTC:ENZC) stock is in focus as well after a recent consolidation. On September 18, Enzolytics signed a binding acquisition agreement regarding the sale of Virogenetics Inc. and Biogenysis Inc., its operating subsidiaries, to Sagaliam Acquisition Coro.
Enzolytics Inc. revealed that the transaction was worth $450,000,000. The combined entity, following the completion of the transaction, would trade on NASDAQ. It was also noted in the news release that the de-SPAC process had been initiated by the concerned parties and that the closure of the transaction was moving in the right direction.
XORTX Therapeutics Inc. (NASDAQ: XRTX) was one of the biggest percentage gainers in Friday’s session as the stock more than doubled on a hefty volume. The big move came in without any news.
Investors may see major stock movement from XRTX next week when the company holds a special shareholder meeting. That’s set to take place on Wednesday and will include a vote for a share consolidation resolution.
https://thestreetreports.com/exploring-undisc...enzc-xrtx/
As the market turned volatile due to on-going war tensions in the Middle East, we have shortlisted a few stocks to watch, which offer impressive valuations: –
Houston Natural Resources Corporation (OTC:HNRC) stock has been hovering around a lower level after hitting a 52-week high of $0.84 in December last year.
The black-check company HNR Acquisition Corp., which had been formed by the oil and gas company, made a major announcement on October 10. Houston Natural announced that it had managed to secure a binding commitment to the tune of $28 million in the form of a secured term loan from Watford City, North Dakota-headquartered First International Bank & Trust (FIBT).
It could be seen as a positive for Houston Natural Resources Corporation as well, and hence, it may be a good time to keep an eye on the stock too. The credit facility would be used to fund a part of the $90 million acquisition of Pogo Resources.
Catheter Precision Inc. (NYSEAMERICAN: VTAK) stock has built up a strong base at a lower level and might see a quick bounce.
On October 12, Catheter Precision Inc. was in focus after it announced that its VIVO 3D mapping system had been granted national reimbursement status in the United Kingdom following its inclusion in the High-Coast Tariff Excluded Devices (HCTED).
HCTED is a supply and purchase system spanning the entire nation for National Health Service England. It had been designed so that products that make the cut for separate payment from the national budget for medical procedures could be paid for.
Enzolytics Inc. (OTC:ENZC) stock is in focus as well after a recent consolidation. On September 18, Enzolytics signed a binding acquisition agreement regarding the sale of Virogenetics Inc. and Biogenysis Inc., its operating subsidiaries, to Sagaliam Acquisition Coro.
Enzolytics Inc. revealed that the transaction was worth $450,000,000. The combined entity, following the completion of the transaction, would trade on NASDAQ. It was also noted in the news release that the de-SPAC process had been initiated by the concerned parties and that the closure of the transaction was moving in the right direction.
XORTX Therapeutics Inc. (NASDAQ: XRTX) was one of the biggest percentage gainers in Friday’s session as the stock more than doubled on a hefty volume. The big move came in without any news.
Investors may see major stock movement from XRTX next week when the company holds a special shareholder meeting. That’s set to take place on Wednesday and will include a vote for a share consolidation resolution.
